From January 1986 to March 1989, 20 patients with stage III and IV cerebello-pontine angle
neurinomas were treated with external fractionated
radiation therapy; seven patients had
phacomatosis. Indications for
radiation therapy were as follows: (a) poor general condition or old age contraindicating surgery, 10 patients; (b) hearing preservation in bilateral
neurinomas after contralateral
tumor removal, 5 patients; (c) partial resection or high risk of recurrence after subsequent surgery for relapse, 4 patients; (d) non-surgical relapse, 1 patient. Most patients were irradiated with a 9 MV
linear accelerator. A 3 to 4-field technique with 5 x 5 cm portals was used. Doses were calculated on a 95% isodose and were given 5 days a week for a mean total dose of 5140 cGy (180 cGy/fraction). Median follow-up from
radiation therapy was 30 months (7 to 46); 4 patients died, 2 with progressive disease. Two patients underwent total
tumor removal after
radiation therapy (1 stable and 1 growing
tumor). On the whole, 14
tumors remained stable, 3 decreased in size, and 3 progressed. CT scan or NMR
tumor changes consistent with partial
tumor necrosis appeared in four cases. Hearing preservation was obtained in 3/5 hearing patients with
phacomatosis. When surgery is not indicated or incomplete, fractionated
radiation therapy appears to be an effective and well-tolerated treatment for stage III and IV
neurinomas. Hearing can be preserved.